Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma

Thomas E. Witzig, Peter H. Wiernik, Timothy Moore, Craig Reeder, Craig Cole, Glen Justice, Henry Kaplan, Michael Voralia, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin-Haynes, Jerome B. Zeldis, Julie M. Vose

Research output: Contribution to journalArticlepeer-review

209 Scopus citations

Fingerprint Dive into the research topics of 'Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences